Results 131 to 140 of about 89,882 (267)

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

Molecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens, Anouk Mentink, Tom Niessink, Frank Coumans, Leonie Mekenkamp, Ruchi Bansal, Jeroen Hiltermann   +6 more
wiley   +1 more source

Analysis of clinical pharmacists' interventions in a rehabilitation setting. [PDF]

J Pharm Policy Pract
Naseralallah L, Noureddine Z, Ahmed A, Al Hail M, Koraysh S.   +4 more
europepmc   +1 more source

Acceptance rate of clinical pharmacists' recommendations-an ongoing journey for integration. [PDF]

Front Pharmacol, 2023
Peled O, Vitzrabin Y, Beit Ner E, Lazaryan M, Berlin M, Barchel D, Berkovitch M, Beer Y, Tamir E.   +8 more
europepmc   +1 more source

Research by Academic Clinical Pharmacists [PDF]

Drug Intelligence & Clinical Pharmacy, 1982
openaire   +2 more sources

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

Molecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra   +16 more
wiley   +1 more source

Integrated pharmaceutical care model by unit-based clinical pharmacists: Implementation and clinical impact. [PDF]

Explor Res Clin Soc Pharm
Feng K, Han X, Lv N, Xiong C, Li Y, Yang B, Yi J, Zhang T.   +7 more
europepmc   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

Molecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder, Klaas de Lint, Hồ Mỹ Phúc Võ, Mariana M. Góis, Rosalie A. Kampen, Marta San Martin Alonso, Ilse Nootenboom, Veronica Garzero, Tiemen J. Wendel, Rob M. F. Wolthuis, Sylvie M. Noordermeer   +10 more
wiley   +1 more source

Resilience among clinical pharmacists and related factors: a cross-sectional study. [PDF]

J Pharm Health Care Sci
Tsuchiya Y, Arai W, Sunami N, Hosono H, Maeshima T, Itagaki F, Watanabe M.   +6 more
europepmc   +1 more source

Clinical pharmacists' involvement in carbapenem antibiotics management at Wenzhou Integrated Hospital. [PDF]

World J Clin Cases, 2023
Xu XM, Pan CY, Zeng DL.
europepmc   +1 more source

The Impact of Clinical Pharmacist Consultation on the Treatment of Multi-Drug Resistant Organisms (MDRO) Infections: A Retrospective Observational Study

Journal of Multidisciplinary Healthcare
Fang Fang, Xiaobo Zhai, Siwei Bao, Xiucong Fan, Rong Bai, Yabin Ma, Xiaohui Dong Department of Pharmacy, Affiliated Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence: Xiaohui Dong, Department
Fang F, Zhai X, Bao S, Fan X, Bai R, Ma Y, Dong X   +6 more
doaj